nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—CHRM3—ureter—kidney cancer	0.132	0.865	CbGeAlD
Propantheline—Dermatitis atopic—Gemcitabine—kidney cancer	0.0152	0.018	CcSEcCtD
Propantheline—Abdominal distension—Temsirolimus—kidney cancer	0.0143	0.0169	CcSEcCtD
Propantheline—Dysphagia—Temsirolimus—kidney cancer	0.0142	0.0168	CcSEcCtD
Propantheline—Abdominal distension—Pazopanib—kidney cancer	0.0135	0.0159	CcSEcCtD
Propantheline—Dermatitis atopic—Paclitaxel—kidney cancer	0.0128	0.0151	CcSEcCtD
Propantheline—Abdominal distension—Everolimus—kidney cancer	0.0106	0.0126	CcSEcCtD
Propantheline—Dysphagia—Everolimus—kidney cancer	0.0106	0.0125	CcSEcCtD
Propantheline—CHRM3—renal system—kidney cancer	0.0105	0.0687	CbGeAlD
Propantheline—Dysphagia—Erlotinib—kidney cancer	0.0102	0.012	CcSEcCtD
Propantheline—CHRM3—kidney—kidney cancer	0.0102	0.0665	CbGeAlD
Propantheline—Flushing—Pazopanib—kidney cancer	0.00994	0.0117	CcSEcCtD
Propantheline—Erectile dysfunction—Everolimus—kidney cancer	0.00973	0.0115	CcSEcCtD
Propantheline—Dysphagia—Sorafenib—kidney cancer	0.00917	0.0108	CcSEcCtD
Propantheline—Abdominal distension—Sunitinib—kidney cancer	0.00888	0.0105	CcSEcCtD
Propantheline—Dysphagia—Sunitinib—kidney cancer	0.00882	0.0104	CcSEcCtD
Propantheline—Vision blurred—Pazopanib—kidney cancer	0.00879	0.0104	CcSEcCtD
Propantheline—Erectile dysfunction—Sorafenib—kidney cancer	0.00845	0.00997	CcSEcCtD
Propantheline—Dysphagia—Dactinomycin—kidney cancer	0.00835	0.00986	CcSEcCtD
Propantheline—Anaphylactic shock—Temsirolimus—kidney cancer	0.00808	0.00953	CcSEcCtD
Propantheline—Flushing—Everolimus—kidney cancer	0.00785	0.00926	CcSEcCtD
Propantheline—Dry mouth—Pazopanib—kidney cancer	0.00776	0.00916	CcSEcCtD
Propantheline—Insomnia—Temsirolimus—kidney cancer	0.0073	0.00862	CcSEcCtD
Propantheline—Somnolence—Temsirolimus—kidney cancer	0.00718	0.00847	CcSEcCtD
Propantheline—Vision blurred—Everolimus—kidney cancer	0.00694	0.00819	CcSEcCtD
Propantheline—Constipation—Temsirolimus—kidney cancer	0.00691	0.00815	CcSEcCtD
Propantheline—Insomnia—Pazopanib—kidney cancer	0.00688	0.00812	CcSEcCtD
Propantheline—Erectile dysfunction—Vincristine—kidney cancer	0.00687	0.00811	CcSEcCtD
Propantheline—Flushing—Sorafenib—kidney cancer	0.00681	0.00804	CcSEcCtD
Propantheline—Somnolence—Pazopanib—kidney cancer	0.00676	0.00798	CcSEcCtD
Propantheline—Dermatitis atopic—Doxorubicin—kidney cancer	0.00675	0.00797	CcSEcCtD
Propantheline—Flushing—Sunitinib—kidney cancer	0.00655	0.00774	CcSEcCtD
Propantheline—Palpitations—Everolimus—kidney cancer	0.0065	0.00768	CcSEcCtD
Propantheline—Flushing—Dactinomycin—kidney cancer	0.00621	0.00732	CcSEcCtD
Propantheline—Dry mouth—Everolimus—kidney cancer	0.00613	0.00723	CcSEcCtD
Propantheline—Abdominal distension—Paclitaxel—kidney cancer	0.00597	0.00704	CcSEcCtD
Propantheline—Hypersensitivity—Temsirolimus—kidney cancer	0.00595	0.00702	CcSEcCtD
Propantheline—Dysphagia—Paclitaxel—kidney cancer	0.00593	0.007	CcSEcCtD
Propantheline—Thirst—Capecitabine—kidney cancer	0.00591	0.00698	CcSEcCtD
Propantheline—Tachycardia—Everolimus—kidney cancer	0.00586	0.00692	CcSEcCtD
Propantheline—Asthenia—Temsirolimus—kidney cancer	0.00579	0.00684	CcSEcCtD
Propantheline—Asthenia—Pazopanib—kidney cancer	0.00546	0.00644	CcSEcCtD
Propantheline—Insomnia—Everolimus—kidney cancer	0.00543	0.00641	CcSEcCtD
Propantheline—Somnolence—Everolimus—kidney cancer	0.00534	0.0063	CcSEcCtD
Propantheline—Dizziness—Temsirolimus—kidney cancer	0.00534	0.0063	CcSEcCtD
Propantheline—Dry mouth—Sorafenib—kidney cancer	0.00532	0.00628	CcSEcCtD
Propantheline—Insomnia—Erlotinib—kidney cancer	0.00524	0.00619	CcSEcCtD
Propantheline—Anaphylactic shock—Sorafenib—kidney cancer	0.00521	0.00616	CcSEcCtD
Propantheline—Constipation—Vinblastine—kidney cancer	0.00516	0.00609	CcSEcCtD
Propantheline—Constipation—Everolimus—kidney cancer	0.00514	0.00606	CcSEcCtD
Propantheline—Vomiting—Temsirolimus—kidney cancer	0.00513	0.00606	CcSEcCtD
Propantheline—Dry mouth—Sunitinib—kidney cancer	0.00512	0.00604	CcSEcCtD
Propantheline—Rash—Temsirolimus—kidney cancer	0.00509	0.00601	CcSEcCtD
Propantheline—Dermatitis—Temsirolimus—kidney cancer	0.00509	0.006	CcSEcCtD
Propantheline—Headache—Temsirolimus—kidney cancer	0.00506	0.00597	CcSEcCtD
Propantheline—Dizziness—Pazopanib—kidney cancer	0.00503	0.00594	CcSEcCtD
Propantheline—Feeling abnormal—Vinblastine—kidney cancer	0.00497	0.00587	CcSEcCtD
Propantheline—Constipation—Erlotinib—kidney cancer	0.00496	0.00585	CcSEcCtD
Propantheline—Feeling abnormal—Everolimus—kidney cancer	0.00495	0.00584	CcSEcCtD
Propantheline—Abdominal distension—Capecitabine—kidney cancer	0.0049	0.00578	CcSEcCtD
Propantheline—Dysphagia—Capecitabine—kidney cancer	0.00486	0.00574	CcSEcCtD
Propantheline—Salivary hypersecretion—Doxorubicin—kidney cancer	0.00485	0.00573	CcSEcCtD
Propantheline—Vomiting—Pazopanib—kidney cancer	0.00484	0.00571	CcSEcCtD
Propantheline—Rash—Pazopanib—kidney cancer	0.0048	0.00566	CcSEcCtD
Propantheline—Nausea—Temsirolimus—kidney cancer	0.0048	0.00566	CcSEcCtD
Propantheline—Dermatitis—Pazopanib—kidney cancer	0.00479	0.00566	CcSEcCtD
Propantheline—Headache—Pazopanib—kidney cancer	0.00477	0.00563	CcSEcCtD
Propantheline—Insomnia—Sunitinib—kidney cancer	0.00454	0.00536	CcSEcCtD
Propantheline—Nausea—Pazopanib—kidney cancer	0.00452	0.00533	CcSEcCtD
Propantheline—Constipation—Sorafenib—kidney cancer	0.00446	0.00526	CcSEcCtD
Propantheline—Hypersensitivity—Vinblastine—kidney cancer	0.00444	0.00524	CcSEcCtD
Propantheline—Hypersensitivity—Everolimus—kidney cancer	0.00443	0.00522	CcSEcCtD
Propantheline—Flushing—Paclitaxel—kidney cancer	0.0044	0.0052	CcSEcCtD
Propantheline—Asthenia—Vinblastine—kidney cancer	0.00433	0.00511	CcSEcCtD
Propantheline—Asthenia—Everolimus—kidney cancer	0.00431	0.00509	CcSEcCtD
Propantheline—Constipation—Sunitinib—kidney cancer	0.00429	0.00506	CcSEcCtD
Propantheline—Anaphylactic shock—Vincristine—kidney cancer	0.00424	0.00501	CcSEcCtD
Propantheline—Asthenia—Erlotinib—kidney cancer	0.00416	0.00491	CcSEcCtD
Propantheline—Urticaria—Sorafenib—kidney cancer	0.00414	0.00489	CcSEcCtD
Propantheline—Tension—Paclitaxel—kidney cancer	0.00405	0.00478	CcSEcCtD
Propantheline—Anaphylactic shock—Gemcitabine—kidney cancer	0.00403	0.00475	CcSEcCtD
Propantheline—Nervousness—Paclitaxel—kidney cancer	0.00401	0.00474	CcSEcCtD
Propantheline—Dizziness—Vinblastine—kidney cancer	0.00399	0.00471	CcSEcCtD
Propantheline—Dizziness—Everolimus—kidney cancer	0.00397	0.00469	CcSEcCtD
Propantheline—Feeling abnormal—Dactinomycin—kidney cancer	0.00391	0.00462	CcSEcCtD
Propantheline—Vision blurred—Paclitaxel—kidney cancer	0.00389	0.00459	CcSEcCtD
Propantheline—Hypersensitivity—Sorafenib—kidney cancer	0.00384	0.00453	CcSEcCtD
Propantheline—Insomnia—Vincristine—kidney cancer	0.00384	0.00453	CcSEcCtD
Propantheline—Vomiting—Vinblastine—kidney cancer	0.00383	0.00453	CcSEcCtD
Propantheline—Dizziness—Erlotinib—kidney cancer	0.00383	0.00452	CcSEcCtD
Propantheline—Vomiting—Everolimus—kidney cancer	0.00382	0.00451	CcSEcCtD
Propantheline—Rash—Everolimus—kidney cancer	0.00379	0.00447	CcSEcCtD
Propantheline—Dermatitis—Everolimus—kidney cancer	0.00378	0.00447	CcSEcCtD
Propantheline—Headache—Vinblastine—kidney cancer	0.00378	0.00446	CcSEcCtD
Propantheline—Headache—Everolimus—kidney cancer	0.00376	0.00444	CcSEcCtD
Propantheline—Asthenia—Sorafenib—kidney cancer	0.00374	0.00442	CcSEcCtD
Propantheline—Hypersensitivity—Sunitinib—kidney cancer	0.0037	0.00436	CcSEcCtD
Propantheline—Vomiting—Erlotinib—kidney cancer	0.00369	0.00435	CcSEcCtD
Propantheline—Rash—Erlotinib—kidney cancer	0.00365	0.00431	CcSEcCtD
Propantheline—Dermatitis—Erlotinib—kidney cancer	0.00365	0.00431	CcSEcCtD
Propantheline—Palpitations—Paclitaxel—kidney cancer	0.00365	0.00431	CcSEcCtD
Propantheline—Insomnia—Gemcitabine—kidney cancer	0.00364	0.0043	CcSEcCtD
Propantheline—Headache—Erlotinib—kidney cancer	0.00363	0.00429	CcSEcCtD
Propantheline—Constipation—Vincristine—kidney cancer	0.00363	0.00428	CcSEcCtD
Propantheline—Flushing—Capecitabine—kidney cancer	0.00361	0.00427	CcSEcCtD
Propantheline—Asthenia—Sunitinib—kidney cancer	0.0036	0.00425	CcSEcCtD
Propantheline—Nausea—Vinblastine—kidney cancer	0.00358	0.00423	CcSEcCtD
Propantheline—Somnolence—Gemcitabine—kidney cancer	0.00358	0.00422	CcSEcCtD
Propantheline—Nausea—Everolimus—kidney cancer	0.00357	0.00421	CcSEcCtD
Propantheline—Hypersensitivity—Dactinomycin—kidney cancer	0.0035	0.00413	CcSEcCtD
Propantheline—Dizziness—Sorafenib—kidney cancer	0.00345	0.00407	CcSEcCtD
Propantheline—Constipation—Gemcitabine—kidney cancer	0.00344	0.00406	CcSEcCtD
Propantheline—Nausea—Erlotinib—kidney cancer	0.00344	0.00406	CcSEcCtD
Propantheline—Dry mouth—Paclitaxel—kidney cancer	0.00344	0.00406	CcSEcCtD
Propantheline—Asthenia—Dactinomycin—kidney cancer	0.00341	0.00402	CcSEcCtD
Propantheline—Confusional state—Paclitaxel—kidney cancer	0.0034	0.00401	CcSEcCtD
Propantheline—Anaphylactic shock—Paclitaxel—kidney cancer	0.00337	0.00398	CcSEcCtD
Propantheline—Dizziness—Sunitinib—kidney cancer	0.00332	0.00392	CcSEcCtD
Propantheline—Feeling abnormal—Gemcitabine—kidney cancer	0.00332	0.00392	CcSEcCtD
Propantheline—Vomiting—Sorafenib—kidney cancer	0.00332	0.00391	CcSEcCtD
Propantheline—Tachycardia—Paclitaxel—kidney cancer	0.00329	0.00388	CcSEcCtD
Propantheline—Rash—Sorafenib—kidney cancer	0.00329	0.00388	CcSEcCtD
Propantheline—Dermatitis—Sorafenib—kidney cancer	0.00328	0.00388	CcSEcCtD
Propantheline—Headache—Sorafenib—kidney cancer	0.00327	0.00386	CcSEcCtD
Propantheline—Vision blurred—Capecitabine—kidney cancer	0.00319	0.00377	CcSEcCtD
Propantheline—Vomiting—Sunitinib—kidney cancer	0.00319	0.00377	CcSEcCtD
Propantheline—Rash—Sunitinib—kidney cancer	0.00316	0.00373	CcSEcCtD
Propantheline—Dermatitis—Sunitinib—kidney cancer	0.00316	0.00373	CcSEcCtD
Propantheline—Abdominal distension—Doxorubicin—kidney cancer	0.00316	0.00373	CcSEcCtD
Propantheline—Headache—Sunitinib—kidney cancer	0.00314	0.00371	CcSEcCtD
Propantheline—Dysphagia—Doxorubicin—kidney cancer	0.00314	0.0037	CcSEcCtD
Propantheline—Hypersensitivity—Vincristine—kidney cancer	0.00313	0.00369	CcSEcCtD
Propantheline—Nausea—Sorafenib—kidney cancer	0.0031	0.00366	CcSEcCtD
Propantheline—Insomnia—Paclitaxel—kidney cancer	0.00305	0.0036	CcSEcCtD
Propantheline—Asthenia—Vincristine—kidney cancer	0.00305	0.00359	CcSEcCtD
Propantheline—Vomiting—Dactinomycin—kidney cancer	0.00302	0.00356	CcSEcCtD
Propantheline—Somnolence—Paclitaxel—kidney cancer	0.003	0.00354	CcSEcCtD
Propantheline—Palpitations—Capecitabine—kidney cancer	0.003	0.00354	CcSEcCtD
Propantheline—Rash—Dactinomycin—kidney cancer	0.003	0.00354	CcSEcCtD
Propantheline—Nausea—Sunitinib—kidney cancer	0.00298	0.00352	CcSEcCtD
Propantheline—Asthenia—Gemcitabine—kidney cancer	0.00289	0.00341	CcSEcCtD
Propantheline—Constipation—Paclitaxel—kidney cancer	0.00288	0.0034	CcSEcCtD
Propantheline—Dry mouth—Capecitabine—kidney cancer	0.00282	0.00333	CcSEcCtD
Propantheline—Nausea—Dactinomycin—kidney cancer	0.00282	0.00333	CcSEcCtD
Propantheline—Dizziness—Vincristine—kidney cancer	0.00281	0.00331	CcSEcCtD
Propantheline—Drowsiness—Doxorubicin—kidney cancer	0.0028	0.0033	CcSEcCtD
Propantheline—Confusional state—Capecitabine—kidney cancer	0.00279	0.00329	CcSEcCtD
Propantheline—Feeling abnormal—Paclitaxel—kidney cancer	0.00278	0.00328	CcSEcCtD
Propantheline—Tachycardia—Capecitabine—kidney cancer	0.0027	0.00319	CcSEcCtD
Propantheline—Vomiting—Vincristine—kidney cancer	0.0027	0.00319	CcSEcCtD
Propantheline—Urticaria—Paclitaxel—kidney cancer	0.00268	0.00316	CcSEcCtD
Propantheline—Rash—Vincristine—kidney cancer	0.00268	0.00316	CcSEcCtD
Propantheline—Dermatitis—Vincristine—kidney cancer	0.00267	0.00316	CcSEcCtD
Propantheline—Headache—Vincristine—kidney cancer	0.00266	0.00314	CcSEcCtD
Propantheline—Vomiting—Gemcitabine—kidney cancer	0.00256	0.00302	CcSEcCtD
Propantheline—Rash—Gemcitabine—kidney cancer	0.00254	0.003	CcSEcCtD
Propantheline—Dermatitis—Gemcitabine—kidney cancer	0.00254	0.00299	CcSEcCtD
Propantheline—Headache—Gemcitabine—kidney cancer	0.00252	0.00298	CcSEcCtD
Propantheline—Nausea—Vincristine—kidney cancer	0.00252	0.00298	CcSEcCtD
Propantheline—Insomnia—Capecitabine—kidney cancer	0.0025	0.00295	CcSEcCtD
Propantheline—Hypersensitivity—Paclitaxel—kidney cancer	0.00248	0.00293	CcSEcCtD
Propantheline—Asthenia—Paclitaxel—kidney cancer	0.00242	0.00285	CcSEcCtD
Propantheline—Nausea—Gemcitabine—kidney cancer	0.00239	0.00282	CcSEcCtD
Propantheline—Constipation—Capecitabine—kidney cancer	0.00237	0.00279	CcSEcCtD
Propantheline—Flushing—Doxorubicin—kidney cancer	0.00233	0.00275	CcSEcCtD
Propantheline—Feeling abnormal—Capecitabine—kidney cancer	0.00228	0.00269	CcSEcCtD
Propantheline—Dizziness—Paclitaxel—kidney cancer	0.00223	0.00263	CcSEcCtD
Propantheline—Urticaria—Capecitabine—kidney cancer	0.0022	0.00259	CcSEcCtD
Propantheline—Tension—Doxorubicin—kidney cancer	0.00214	0.00253	CcSEcCtD
Propantheline—Vomiting—Paclitaxel—kidney cancer	0.00214	0.00253	CcSEcCtD
Propantheline—Rash—Paclitaxel—kidney cancer	0.00213	0.00251	CcSEcCtD
Propantheline—Dermatitis—Paclitaxel—kidney cancer	0.00212	0.00251	CcSEcCtD
Propantheline—Nervousness—Doxorubicin—kidney cancer	0.00212	0.0025	CcSEcCtD
Propantheline—Headache—Paclitaxel—kidney cancer	0.00211	0.00249	CcSEcCtD
Propantheline—Vision blurred—Doxorubicin—kidney cancer	0.00206	0.00243	CcSEcCtD
Propantheline—Hypersensitivity—Capecitabine—kidney cancer	0.00204	0.00241	CcSEcCtD
Propantheline—Nausea—Paclitaxel—kidney cancer	0.002	0.00236	CcSEcCtD
Propantheline—Asthenia—Capecitabine—kidney cancer	0.00198	0.00234	CcSEcCtD
Propantheline—Palpitations—Doxorubicin—kidney cancer	0.00193	0.00228	CcSEcCtD
Propantheline—Dizziness—Capecitabine—kidney cancer	0.00183	0.00216	CcSEcCtD
Propantheline—Dry mouth—Doxorubicin—kidney cancer	0.00182	0.00215	CcSEcCtD
Propantheline—Confusional state—Doxorubicin—kidney cancer	0.0018	0.00212	CcSEcCtD
Propantheline—Anaphylactic shock—Doxorubicin—kidney cancer	0.00178	0.0021	CcSEcCtD
Propantheline—Vomiting—Capecitabine—kidney cancer	0.00176	0.00208	CcSEcCtD
Propantheline—Rash—Capecitabine—kidney cancer	0.00174	0.00206	CcSEcCtD
Propantheline—Dermatitis—Capecitabine—kidney cancer	0.00174	0.00206	CcSEcCtD
Propantheline—Tachycardia—Doxorubicin—kidney cancer	0.00174	0.00205	CcSEcCtD
Propantheline—Headache—Capecitabine—kidney cancer	0.00173	0.00205	CcSEcCtD
Propantheline—Nausea—Capecitabine—kidney cancer	0.00164	0.00194	CcSEcCtD
Propantheline—Insomnia—Doxorubicin—kidney cancer	0.00161	0.0019	CcSEcCtD
Propantheline—Somnolence—Doxorubicin—kidney cancer	0.00159	0.00187	CcSEcCtD
Propantheline—Constipation—Doxorubicin—kidney cancer	0.00152	0.0018	CcSEcCtD
Propantheline—Feeling abnormal—Doxorubicin—kidney cancer	0.00147	0.00173	CcSEcCtD
Propantheline—Urticaria—Doxorubicin—kidney cancer	0.00142	0.00167	CcSEcCtD
Propantheline—Hypersensitivity—Doxorubicin—kidney cancer	0.00131	0.00155	CcSEcCtD
Propantheline—Asthenia—Doxorubicin—kidney cancer	0.00128	0.00151	CcSEcCtD
Propantheline—Dizziness—Doxorubicin—kidney cancer	0.00118	0.00139	CcSEcCtD
Propantheline—Vomiting—Doxorubicin—kidney cancer	0.00113	0.00134	CcSEcCtD
Propantheline—Rash—Doxorubicin—kidney cancer	0.00112	0.00133	CcSEcCtD
Propantheline—Dermatitis—Doxorubicin—kidney cancer	0.00112	0.00133	CcSEcCtD
Propantheline—Headache—Doxorubicin—kidney cancer	0.00112	0.00132	CcSEcCtD
Propantheline—Nausea—Doxorubicin—kidney cancer	0.00106	0.00125	CcSEcCtD
